The same PI for two studies in the same time [Study As­sess­ment]

posted by wienui  – Germany/Oman, 2020-01-06 05:05 (1128 d 09:53 ago) – Posting: # 21059
Views: 2,871

Dear Cap't'n,

❝ Is this an issue at all?


I think the risk of Mixing up is high when the PI and his/her clinical team are involved in both studies at the same time, think about adverse events which could be happened and his/her responsibility for the protection of study subjects, Mixing up in the collection of subjects study samples , ....etc


❝ In some countries the PI is purely an administrative matter; she or he will not see the subjects/patients but have everything delegated.


I know that in some very rare cases that the PI has purely an administrative job, but mostely he/she is a physician who do practically the clinical part from A to Z.

Best regards,
Osama

Cheers,
Osama

Complete thread:

UA Flag
Activity
 Admin contact
22,485 posts in 4,710 threads, 1,603 registered users;
16 visitors (0 registered, 16 guests [including 6 identified bots]).
Forum time: 14:58 CET (Europe/Vienna)

The difference between a surrogate and a true endpoint
is like the difference between a cheque and cash.
You can get the cheque earlier but then,
of course, it might bounce.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5